Anupriya Behki
About Anupriya Behki
Anupriya Behki is a Senior Research Associate at Kite Pharma, specializing in drug discovery and gene therapy development. She has a strong educational background in biotechnology and patent laws, along with experience in flow cytometry and genome editing techniques.
Work at Kite Pharma
Anupriya Behki has been employed at Kite Pharma as a Senior Research Associate since 2020. In this role, she focuses on drug discovery and the development of new therapeutic solutions. Her work contributes to the advancement of gene therapy, particularly in the purification of AAV viruses, which are essential for effective gene therapy applications. Kite Pharma operates in the San Francisco Bay Area, where Behki applies her expertise in biotechnology and genetic engineering.
Previous Experience in Research and Development
Prior to her current position, Behki worked at A2 Biotherapeutics, Inc. as a Research Associate from 2019 to 2020. She also held a position as a CIRM Bridges Scholar at Stanford University from 2018 to 2019. Earlier in her career, she served as a Senior IP Associate at CPA Global for five months in 2015. These roles have provided her with a diverse background in research and intellectual property within the biotechnology sector.
Education and Expertise
Anupriya Behki holds a Master of Science degree in Biotechnology with an emphasis on Stem Cell Technology from California State University-Channel Islands, which she completed from 2017 to 2019. She earned a Post Graduate Diploma in Patent Laws from the National Academy of Legal Studies and Research University in 2015. Additionally, she obtained a Bachelor of Technology in Biotechnology from Jaypee University of Information Technology between 2010 and 2014. Her educational background equips her with a strong foundation in both biotechnology and legal aspects of intellectual property.
Technical Skills and Specializations
Behki possesses a range of technical skills relevant to her field. She is experienced in flow cytometry, a critical technique for cell analysis in research and clinical settings. Her expertise extends to plasmid designing and construction, which are vital for genetic engineering projects. Additionally, she specializes in CRISPR/Cas9 based genome editing, a leading-edge technology in genetic research, and AAV virus purification, which is crucial for gene therapy development.
Early Education
Anupriya Behki completed her secondary education at Essar International School in Hazira, Surat, where she achieved an SSC score of 87.4%. This foundational education set the stage for her subsequent studies in biotechnology and legal aspects of intellectual property.